Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exercise testing after myocardial infarction: with or without therapy? How does thrombolysis affects its

Paola Bernabò1, Gianfranco Mazzotta

  • 1Divisione di Cardiologia, E.O. Ospedali Galliera, Via Volta 8, 16128 Genova. paola.bernabo@galliera.it

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|June 28, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phospho-RNA sequencing with circAID-p-seq.

Nucleic acids research·2021
Same author

One-shot analysis of translated mammalian lncRNAs with AHARIBO.

eLife·2021
Same author

SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy.

Nature cell biology·2020
Same author

A long noncoding RNA acts as a post-transcriptional regulator of heat shock protein (HSP70) synthesis in the cold hardy Diamesa tonsa under heat shock.

PloS one·2020
Same author

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study.

Clinical cardiology·2019
Same author

Active Ribosome Profiling with RiboLace.

Cell reports·2018

Beta-blocker therapy is crucial for myocardial infarction treatment. Predischarge exercise testing during beta-blocker therapy is recommended for accurate risk assessment in post-infarction patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta-blocker therapy is vital in managing myocardial infarction, including the early post-infarction phase.
  • Management of beta-blocker therapy requires careful titration and washout periods, similar to other anti-ischemic agents like nitroglycerin and calcium channel blockers.

Purpose of the Study:

  • To emphasize the importance of continuing beta-blocker therapy in the early post-infarction period.
  • To advocate for predischarge exercise testing while patients are on beta-blocker therapy.

Main Methods:

  • Review and analysis of the role of beta-blockers in post-myocardial infarction care.
  • Evaluation of the impact of beta-blocker therapy on the diagnostic sensitivity and prognostic accuracy of predischarge exercise testing.

Main Results:

Related Experiment Videos

  • Beta-blockers may reduce the sensitivity of exercise testing for inducible ischemia but do not negatively impact its prognostic accuracy.
  • Ischemia detected during beta-blocker therapy often indicates low clinical risk, while ischemia persisting despite therapy suggests higher risk requiring revascularization.
  • Exercise testing is more frequently positive in patients receiving thrombolytic therapy, likely due to residual stenosis, impacting the test's negative predictive value for reinfarction and plaque instability events.

Conclusions:

  • Discontinuation of beta-blocker therapy in the early post-infarction phase is unadvisable.
  • Predischarge exercise testing should be performed while patients are maintained on beta-blocker therapy.
  • While beta-blockers can mask some inducible ischemia, they help identify high-risk patients who may benefit from revascularization.